Mulia Boga Raya Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Mulia Boga Raya Tbk trades at Rp600 (market cap 3.37T, 52.8K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mulia Boga Raya Tbk is far larger — about 32.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| KEJU | SCPI | |
|---|---|---|
Market Cap | 3.37T | 104.4B |
Volume | 52.8K | — |
Lot | 528 | — |
Turnover | 31.47M | — |
Average Price | 595.95 | — |
Value | 31.47M | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Mulia Boga Raya Tbk (the Company) was established based on Notarial Deed No. 25 of Makmur Tridharma, S.H., dated August 25, 2006. The Company started its commercial operationsin July 2008.
Read more on KEJU →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →